ID 454407277 · FY 2018–2024 · 7 years
კომპანიის ძირითად საქმიანობას წარმოადგენს სამედიცინო და ორთოპედიული საქონლით საცალო ვაჭრობა სპეციალიზებულ მაღაზიებში.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross Margin | 27.7% | 27.5% | 33.5% | 26.8% | 32.7% | 32.4% | 36.6% |
| EBITDA Margin | 20.5% | 21.9% | 26.9% | 22.0% | 25.3% | 26.7% | 36.3% |
| EBITDAR | 504 | 709 | 645 | 857 | 944 | 1,279 | 1,298 |
| EBITDAR Margin | 20.5% | 21.9% | 26.9% | 22.0% | 25.3% | 26.7% | 36.3% |
| EBIT Margin | 19.3% | 21.0% | 26.9% | 22.0% | 25.3% | 26.7% | 36.3% |
| Net Profit Margin | 19.9% | 20.1% | 28.6% | 21.1% | 22.2% | 23.0% | 32.1% |
| Operating Expense % of Sales | 7.1% | 5.6% | 6.7% | 4.8% | 7.4% | 5.7% | 0.3% |
| Returns | |||||||
| Return on Assets (ROA) | 31.9% | 30.8% | 28.8% | 28.6% | 24.7% | 34.2% | 33.9% |
| Return on Equity (ROE) | 46.2% | 38.0% | 31.5% | 30.5% | 29.1% | 37.7% | 34.1% |
| ROIC [EBIT / Invested Capital] | 38.7% | 38.6% | 31.9% | 37.0% | 42.9% | 65.1% | 62.1% |
| Leverage & liquidity | |||||||
| Debt-to-Assets | 11.0% | 8.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.16x | 0.11x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.33x | 0.26x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 69.1% | 81.0% | 91.5% | 93.9% | 84.9% | 90.7% | 99.6% |
| Net Debt | 167 | 49 | -159 | -381 | -640 | -957 | -1,272 |
| Cash & Equivalents | 2 | 138 | 159 | 381 | 640 | 957 | 1,272 |
| Total Debt | 169 | 187 | N/A | N/A | N/A | N/A | N/A |
| Efficiency & working capital | |||||||
| Inventory Turnover | 1.89x | 1.35x | 0.89x | 1.36x | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 193.2 | 269.7 | 409.6 | 268.2 | N/A | N/A | N/A |
| Receivables Turnover | 5.30x | 21.53x | 6.51x | 12.57x | 52.04x | 5.91x | 5.28x |
| Days Sales Outstanding (DSO) | 68.8 | 17.0 | 56.0 | 29.0 | 7.0 | 61.8 | 69.2 |
| Payables Turnover | 5.83x | 11.03x | 7.87x | 16.25x | 5.11x | 11.62x | 150.87x |
| Days Payable Outstanding (DPO) | 62.6 | 33.1 | 46.4 | 22.5 | 71.5 | 31.4 | 2.4 |
| Cash Conversion Cycle | 199.4 days | 253.5 days | 419.3 days | 274.8 days | -64.5 days | 30.4 days | 66.7 days |
| Asset Turnover | 1.60x | 1.53x | 1.01x | 1.36x | 1.11x | 1.48x | 1.06x |
| Cash flow & dividends | |||||||
| Operating Cash Flow | -54 | 162 | 370 | 546 | 939 | 1,450 | 5,945 |
| Free Cash Flow (OCF − Capex proxy) | -56 | 157 | 370 | 546 | 939 | 1,277 | 5,943 |
| Cash Conversion (OCF / EBITDA) | -10.6% | 22.8% | 57.4% | 63.8% | 99.5% | 113.4% | 457.8% |
| Dividends Declared | 0 | 0 | 239 | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | 0.0% | 0.0% | 34.9% | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2018 ₾0 · FY2019 ₾0 · FY2020 ₾239k — 3-yr total ₾239k